Profile for Pluristem Therapeutics, Inc. (PSTI)
« Back to company indexPSTI Chatter Timeline
Stock Ticker for PSTI
Most Active Tweeters for PSTI
| User | Tweets |
|---|---|
| @biotech_sector | 8 |
| @TickerReport | 2 |
| @etkoinc | 2 |
| @TheMarketsDaily | 2 |
| @emq_news | 2 |
Recent Tweets for PSTI
 |
@cperez00jvprny CELL THERAPY - PLX-R18: Cell Therapy for Treatment of Acute Radiation Syndrome & Bone Marrow Failure Diseases https://t.co/CnCTfiRzeU $PSTI July 19th 2017, 1:07pm |
 |
@Robert_JVPRNY CELL THERAPY - PLX-R18: Cell Therapy for Treatment of Acute Radiation Syndrome & Bone Marrow Failure Diseases https://t.co/e1FXOEZB3Z $PSTI July 19th 2017, 12:07pm |
 |
@nicholasjvpr CELL THERAPY - PLX-R18: Cell Therapy for Treatment of Acute Radiation Syndrome & Bone Marrow Failure Diseases https://t.co/mLVwuk7D7a $PSTI July 19th 2017, 12:07pm |
 |
@Pluristem CELL THERAPY - PLX-R18: Cell Therapy for Treatment of Acute Radiation Syndrome & Bone Marrow Failure Diseases https://t.co/fEfDCG5Zzk $PSTI July 19th 2017, 11:07am |
 |
@SPNewsAnalysis Pluristem Therapeutics $PSTI Given Coverage Optimism Rating of 0.56 https://t.co/PAliaH6ex1 July 14th 2017, 1:07pm |
 |
@dailypoliticaln Pluristem Therapeutics $PSTI Given Coverage Optimism Rating of 0.56 https://t.co/5jGZOGCcd7 July 14th 2017, 9:07am |
 |
@etkoinc RT @dailypoliticaln: Pluristem Therapeutics, Inc. $PSTI PT Set at $2.00 by Maxim Group https://t.co/I9EeeFRtly July 14th 2017, 9:07am |
|
@etkoinc RT @GantosJ: $PSTI Pluristem Successful ARS Trial Opens The Door For Cancer Support Treatment? https://t.co/vsm7rQQ9RM July 14th 2017, 9:07am |
|
@dailypoliticaln Pluristem Therapeutics, Inc. $PSTI PT Set at $2.00 by Maxim Group https://t.co/I9EeeFRtly July 14th 2017, 5:07am |
 |
@GantosJ $PSTI Pluristem Successful ARS Trial Opens The Door For Cancer Support Treatment? https://t.co/vsm7rQQ9RM July 13th 2017, 3:07pm |
 |
@biotech_sector #Pluristem A placenta cell medication could help the U.S. get through a nuclear meltdown. Read more: https://t.co/UsKAPKgR1L $PSTI July 13th 2017, 2:07pm |
|
@biotech_sector #Pluristem Therapeutics Advances Its Multinational Phase III Critical Limb Ischemia Study, ... Read more: https://t.co/qNsqkAho92 $PSTI July 13th 2017, 2:07pm |
|
@GantosJ This new drug could help the U.S survive a nuclear meltdown! ARS Acute Radiation Syndrome $PSTI working in Fukushima https://t.co/cKlOaHoJ0X July 13th 2017, 12:07pm |
 |
@midetimes Pluristem Therapeutics, Inc. $PSTI Shares Bought by Jane Street Group LLC https://t.co/a5pksOFmBS July 13th 2017, 7:07am |
 |
@storminvestor Pluristem Therapeutics, Inc. $PSTI PT Set at $2.00 by Maxim Group https://t.co/et6gkD9LYO July 12th 2017, 2:07pm |
 |
@emq_news Pluristem Therapeutics, Inc. $PSTI PT Set at $2.00 by Maxim Group https://t.co/HSz2Lt9OUZ July 12th 2017, 11:07am |
 |
@ZolmaxNews Pluristem Therapeutics, Inc. $PSTI Given a $2.00 Price Target by Maxim Group Analysts https://t.co/ExOdWDlh1a July 11th 2017, 6:07pm |
 |
@dakotafinancial Pluristem Therapeutics, Inc. $PSTI Given a $2.00 Price Target by Maxim Group Analysts https://t.co/sR58WIm6a4 July 11th 2017, 6:07pm |
 |
@WKRBNews Pluristem Therapeutics $PSTI Receiving Favorable Press Coverage, Report Shows https://t.co/qXAO78qb1Z July 11th 2017, 4:07pm |
 |
@chaffeybreeze Pluristem Therapeutics $PSTI Receiving Favorable Press Coverage, Report Shows https://t.co/lD5c8zhfIr July 11th 2017, 4:07pm |
|
@WKRBNews Pluristem Therapeutics $PSTI Receiving Favorable Press Coverage, Report Shows https://t.co/MSx9Am0v13 July 11th 2017, 4:07pm |
 |
@TheMarketsDaily Oppenheimer & Co. Inc. Has $156,000 Position in Pluristem Therapeutics, Inc. $PSTI https://t.co/KMNqvK9eeY July 11th 2017, 10:07am |
 |
@WatchlistN Oppenheimer & Co. Inc. Has $156,000 Position in Pluristem Therapeutics, Inc. $PSTI https://t.co/mpDxThCWlN July 11th 2017, 7:07am |
 |
@JGRcapital $PSTI Pluristem Advances its Multinational Phase III Critical Limb Ischemia Study, Targeting Initiation @Pluristem https://t.co/39o92E9sSp July 10th 2017, 6:07pm |
|
@biotech_sector #Pluristem Therapeutics Advances Its Multinational Phase III Critical Limb Ischemia Study, ... Read more: https://t.co/EamKc35JPn $PSTI July 10th 2017, 3:07pm |
|
@biotech_sector #Pluristem Therapeutics Advances Its Multinational Phase III Critical Limb Ischemia Study, ... Read more: https://t.co/cZtgNtdvrd $PSTI July 10th 2017, 1:07pm |
|
@TheMarketsDaily Maxim Group Reaffirms “Buy” Rating for Pluristem Therapeutics, Inc. $PSTI https://t.co/EMXd5Wicq5 July 10th 2017, 1:07pm |
 |
@intercooleronli Pluristem Therapeutics, Inc. $PSTI Receives Buy Rating from Maxim Group https://t.co/v7sQ91axhs July 10th 2017, 11:07am |
|
@WatchlistN Maxim Group Reaffirms “Buy” Rating for Pluristem Therapeutics, Inc. $PSTI https://t.co/lya2VrY3Vs July 10th 2017, 11:07am |
 |
@RatingsNetwork Pluristem Therapeutics's buy rating reiterated at Maxim Group. $2.00 PT. https://t.co/CaCPB6Yd02 $PSTI #PSTI July 10th 2017, 11:07am |
 |
@ARatings Maxim Group Remains a Buy on Pluristem $PSTI https://t.co/hwlQDUZ7eX July 10th 2017, 11:07am |
 |
@pennyomegaCRWE $PSTI Advances its Multinational Late-Stage Critical Limb Ischemia Study https://t.co/92ePdhSN11 July 10th 2017, 11:07am |
 |
@StockNewsNow $PSTI Pluristem Advances its Multinational Phase III Critical Limb Ischemia Study, Targeting Initiation at 40... https://t.co/yjTzyIG4Oq July 10th 2017, 9:07am |
|
@biotech_sector #Pluristem Oramed to dual list on TASE. Read more: https://t.co/M1S1smTbjW $PSTI July 10th 2017, 8:07am |
|
@biotech_sector BRIEF-#Pluristem Therapeutics says on July 7, co entered into an at market issuance sales a... Read more: https://t.co/OkoLEVvDrL $PSTI July 10th 2017, 8:07am |
 |
@YoungChris27040 RT @odibro: $PSTI Advances its Multinational P3 CLI Study, Targeting Initiation at 40 Active Sites by the End of 2017 https://t.co/Uxovg9z… July 10th 2017, 7:07am |
 |
@odibro $PSTI Advances its Multinational P3 CLI Study, Targeting Initiation at 40 Active Sites by the End of 2017 https://t.co/Uxovg9zdC2 July 10th 2017, 7:07am |
 |
@tickerws $PSTI advances Phase III trial of PLX-PAD cells to treat CLI https://t.co/PnidtAkm3k July 10th 2017, 7:07am |
 |
@ProTradersNews $PSTI: Pluristem Therapeutics (PSTI) Advances Multinational Phase III …: https://t.co/0CfzvGQbv6 July 10th 2017, 7:07am |
 |
@newswelldone $PSTI: Pluristem Advances its Multinational Phase III Critical Limb Ischemia …: https://t.co/SThNRv0yp8 July 10th 2017, 7:07am |
 |
@stockboardinc $PSTI Pluristem Advances its Multinational Phase III Critical Limb Ischemia Study, Targeting Initiation at... - https://t.co/S8fa94R6ev July 10th 2017, 7:07am |
 |
@VisualStockRSRC $PSTI - Pluristem Advances its Multinational Phase III Critical Limb Ischemia Study, Targeting Initiation at 40 https://t.co/DfSpSmK5Gk July 10th 2017, 7:07am |
 |
@GNWLive Pluristem Advances its Multinational Phase III Critical Limb Ischemia Study, Targeting Initiation at 40 $PSTI https://t.co/QezMaAcGge July 10th 2017, 7:07am |
 |
@TickerReport Pluristem Therapeutics $PSTI Given News Sentiment Rating of 0.43 https://t.co/LNKxoZREfP July 8th 2017, 8:07am |
|
@emq_news Pluristem Therapeutics $PSTI Given News Sentiment Rating of 0.43 https://t.co/xM5NUQsy3T July 8th 2017, 8:07am |
|
@TickerReport Pluristem Therapeutics $PSTI Given News Sentiment Rating of 0.43 https://t.co/FyENzSDEHN July 8th 2017, 8:07am |
 |
@MaisaCorp $PSTI S-3 for $80M July 7th 2017, 3:07pm |
|
@biotech_sector BRIEF-#Pluristem Therapeutics says on July 7, co entered into an at market issuance sales a... Read more: https://t.co/mR6MlUpdWZ $PSTI July 7th 2017, 10:07am |
|
@VisualStockRSRC $PSTI - Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) https://t.co/TSQdsPlAdp July 7th 2017, 8:07am |
 |
@confcalltran Entry into a Material Definitive https://t.co/5bPJ1cI8TT $PSTI July 7th 2017, 8:07am |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.